CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Pangaea Oncology SA is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Pangaea Oncology SA
Quiron Dexeus University Hospital
C/ Sabino Arana, 5-19
Phone: +34 934097981p:+34 934097981 BARCELONA, BAR  08028  Spain Ticker: PANGPANG

Business Summary
Pangaea Oncology SA is a Spain-based company primarily engaged in the biotechnology sector. The Company focuses on the development of oncology treatments. The Company’s activities are divided into two business lines: Clinical care in the Dr. Rosell Oncology Institute (IOR) and Molecular diagnosis (Dx). The IOR division offers personalized medical services related to oncology area, such as diagnosis, laboratory testing and treatment, in a chain of hospitals in Catalonia, Spain. The Dx division is responsible for the development of diagnostic and in-vitro services, biomarkers, as well as targeted drugs for patients and pharmaceutical companies. Its diagnostic models include Liquid Biopsy and Multiplexing.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/202312/31/2022Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Executive Chairman of the Board, Representative of Topgenetics, SLU, Co-Founder, Chief Scientific O RafaelRosell Costa 11/2/2016 11/2/2016
Chief Executive Officer, Co-Founder, Executive Director JavierRivela Rodriguez 11/2/2016 11/2/2016
Vice Chairman of the Board, Proprietary Director, Representative of Biolifepat, SL, Director - Mole SantiagoRamon y Cajal Agueras 11/2/2016 11/2/2016
9 additional Officers and Directors records available in full report.

General Information
Number of Employees: 62 (As of 6/30/2023)
Outstanding Shares: 29,445,740 (As of 6/30/2023)
Stock Exchange: MCE
Fax Number: +34 935460172


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, March 29, 2024